InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-16 · accession 0001106578-25-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2025-09-17 2025-09-16 UTHR ROTHBLATT MARTINE A COB, CEO, Dir S - Sale+OE $400.26 -4,000 130 -97% -$1.60M
DT 2025-09-17 2025-09-16 UTHR ROTHBLATT MARTINE A COB, CEO, Dir M - OptEx $120.26 +4,000 4,130 +3,077% +$481.0K
DT 2025-09-17 2025-09-16 UTHR ROTHBLATT MARTINE A COB, CEO, Dir M - OptEx $0.00 -4,000 266.0K -1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-16 S D 1,000 $399.28 3,130 D — — (F2) This transaction was executed in multiple trades at prices ranging from $399.25 to $399.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2025-09-16 S D 3,000 $400.59 130 D — — (F3) This transaction was executed in multiple trades at prices ranging from $400.27 to $401.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2025-09-16 M A 4,000 $120.26 4,130 D — —
4 Derivative Stock Option 2025-09-16 M D 4,000 $0.00 266,000 D $120.26 · 2016-03-15 to 2026-03-15 4,000 Common Stock